Actionable news
All posts from Actionable news
Actionable news in GSK: GLAXOSMITHKLINE PLC,

Glaxo Gains Jefferies Upgrade on Stronger HIV Drugs Performance, Currency Benefits

Formerly an embodiment of what boardroom inertia can do to a company in a competitive and evolving market, Glaxosmithkline's (GSK) proverbial stock continued to rise on Thursday after analysts at Jefferies upgraded the drugmaker to buy. They slapped a price target of 2,000 pence ($26) on the stock, up from 1,650 pence, which implies upside of around 27% from current levels.

Jefferies analysts cite improving dividend cover and the likelihood of...